House Bill 761
2017-2018 Regular Session
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Co-Sponsorship Memo
Prime Sponsor
Representative Bryan Barbin
D House District 71
Co-Sponsors
Rep. Ron Marsico
R House District 105
Rep. Adam Harris
R House District 82
Rep. Daniel McNeill
D House District 133
Rep. David Millard
R House District 109
Rep. Anthony DeLuca
D House District 32
Rep. Harry Readshaw
D House District 36
Bill Status & History
Last Action: Referred to Judiciary, March 9, 2017
House
H
S
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
This bill amends the act of April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The. Other bills amending the same statute are listed below.
Rep. Matthew Baker
R House District 68
Rep. Ed Gainey
D House District 24
Rep. Ed Gainey
D House District 24
Rep. Dom Costa
D House District 21
Rep. Tedd Nesbit
R House District 8
Only the first 5 bills are included here. Looking for more?
View all legislation amending the act of
April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The
House Bill 761
2017-2018 Regular Session
Sponsors
BARBIN, MARSICO, A. HARRIS, McNEILL, MILLARD, DeLUCA, READSHAW
Short Title
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Memo Subject
Response to Opioid Overdose Deaths
Actions
| 0838 | Referred to JUDICIARY, March 9, 2017 |
Generated 05/20/2025 07:47 PM